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Leptin has been believed to exert its weight-reducing
action not only by inducing hypophagia but also by
increasing energy expenditure/thermogenesis. Lep-
tin-deficient ob/ob mice have correspondingly been
thought to be thermogenically limited and to show
hypothermia, mainly due to atrophied brown adipose
tissue (BAT). In contrast to these established views,
we found that BAT is fully functional and that leptin
treatment did not increase thermogenesis in wild-
type or in ob/ob mice. Rather, ob/ob mice showed
a decreased but defended body temperature (i.e.,
were anapyrexic, not hypothermic) that was normal-
ized to wild-type levels after leptin treatment. This
was not accompanied by increased energy expendi-
ture or BAT recruitment but, instead, was mediated
by decreased tail heat loss. The weight-reducing
hypophagic effects of leptin are, therefore, not
augmented through a thermogenic effect of leptin;
leptin is, however, pyrexic, i.e., it alters centrally
regulated thresholds of thermoregulatory mecha-
nisms, in parallel to effects of other cytokines.
INTRODUCTION
A large number of physiological effects are attributed to leptin
(Friedman, 2014). However, it is in its role as regulator of body
weight that leptin has accrued the most interest. Particularly,
there is a general notion that leptin reduces body weight through
both a reduction of food intake and an increase in thermogene-
sis/energy expenditure (EE) (Cannon and Nedergaard, 2004;
Haynes, 2000; Himms-Hagen, 1999; Kalil and Haynes, 2012;
Mantzoros, 1999; Mark, 2013; Park and Ahima, 2015; Rahmouni,
2010; Rezai-Zadeh and M€unzberg, 2013; Simonds et al., 2012).
Whereas a multitude of investigations have, over the years,
detailed the pathways involved in the hypophagic effect of leptin,
only a few studies have addressed the suggested thermogenicCell Rpathway (Breslow et al., 1999; Commins et al., 1999; Hwa
et al., 1997; Morrison, 2004; Scarpace et al., 1997).
That leptin should be thermogenic is based, e.g., on observa-
tions that the absence of leptin (as in the ob/ob mice) has been
associated with hypometabolism and hypothermia (Bray and
York, 1979; Kaiyala et al., 2015; Pelleymounter et al., 1995)
and with brown adipose tissue (BAT) inactivation (Ashwell
et al., 1985; Bas et al., 1983; Himms-Hagen and Desautels,
1978). Accordingly, one effect of leptin would be to induce ther-
mogenesis by the activation of BAT and, through this, to coun-
teract hypothermia and promote body weight loss. However,
we conclude here that the protective effects of leptin in body
weight regulation do not involve an increase in EE.
RESULTS
No Acute Thermogenic Response to Leptin
To investigate whether leptin—by, e.g., activation of the sympa-
thetic nerves (Kalil and Haynes, 2012) innervating BAT—has a
direct, acute thermogenic effect, we examined the thermogenic
response to acute leptin treatment.
First, we verified the ability of BAT to respond to a thermogenic
stimulus by performing indirect calorimetry on wild-type (WT)
C57BL/6 mice injected with the b3-agonist CL316,243. As seen
(Figure 1A), treatment with CL316,243 caused amarked increase
in oxygen consumption. However, different doses of leptin (as
used in the literature) did not cause any increase in oxygen
consumption (Figure 1B). Thus, at least under these standard
conditions, leptin was not an acute thermogenic agent.
The aforementioned experiments were performed in pento-
barbital-anesthetized mice. Although pentobarbital—in contrast
to, e.g., isoflurane—does not inhibit BAT thermogenesis (Ohlson
et al., 2003, 1994; Virtue and Vidal-Puig, 2013), we further
analyzed the effects of acute leptin injections on EE in conscious,
ambulatory WT mice. Also, under these conditions, leptin injec-
tions did not increase EE (Figure 1C).
To exclude the possibility that the absence of a thermogenic
effect of leptin may be due to an already saturated leptin system
in WT mice (Leibel, 2002), we injected the leptin-deficient ob/ob
mice with leptin. Leptin treatment of ob/ob mice did not alter EEeports 14, 1621–1631, February 23, 2016 ª2016 The Authors 1621
Figure 1. No Acute Thermogenic Response to Leptin
Male WT mice were injected with the b3-agonist CL316,243 or saline or different doses of leptin to measure acute thermogenic effects of leptin.
(A) Acute effect of 1 mg/kg CL316,243 (CL) on oxygen consumption (V(O2)) in anesthetized male WT mice. n = 6.
(B) Acute effect of different doses of leptin on oxygen consumption in anesthetized male WT mice; n = 2 for each dose; SEM not shown.
(C and D) Effects of 5 mg/kg leptin on EE in conscious WT mice (C) and ob/ob mice (D) housed and measured at 21C. Arrows indicate injections.
(E) Effects of leptin treatment on food intake at 21C. Food intake was measured during 24 hr before treatment and 24 hr after injections. The difference in 24-hr
food intake between pre-treatment and post-treatment levels is shown. Pre-treatment levels (g/24 hr) were: WT saline, 4.5 ± 0.2; WT leptin, 4.3 ± 0.2; ob/ob
saline, 4.7 ± 0.3; ob/ob leptin, 4.2 ± 0.2.
(F and G) Effects of 5 mg/kg leptin on EE in WT mice (F) and ob/ob mice (G) housed at 21C and measured at 30C.
(H) Effects of leptin treatment on food intake at 30C. Pre-treatment levels were: WT saline, 3.2 ± 0.2; WT leptin, 3.1 ± 0.1; ob/ob saline, 3.3 ± 0.2; ob/ob leptin,
3.2 ± 0.1.
In (C)–(H), n = 5–6. Data indicate means ± SEM. *p# 0.05; **p# 0.01; ***p# 0.001, significant differences between treatments calculated using Student’s t test.
See also Figure S1.(Figure 1D). The lack of effect was not age dependent, as we also
failed to detect thermogenic effects of leptin in 7- to 8-week-old
ob/ob mice (Figure S1B). To validate the efficacy of the leptin
injections, we measured its effect on food intake in both WT
and ob/ob mice. As expected, leptin treatment resulted in a sig-
nificant reduction of food intake, as compared to saline-treated
controls (Figure 1E).
At environmental temperatures below thermoneutrality,
possible effects of thermogenic agents can be masked by a
compensatory decrease in thermoregulatory thermogenesis,
i.e., the heat production occurring in order to defend the body1622 Cell Reports 14, 1621–1631, February 23, 2016 ª2016 The Authtemperature. This makes the agent-induced thermogenic effect
invisible (Goldgof et al., 2014; Nedergaard and Cannon, 2014;
Shemano and Nickerson, 1963). Therefore, the experiments
were repeated at thermoneutrality, i.e., within the environ-
mental temperature zone where no heat-production is needed
to compensate for heat loss to maintain stable body tempera-
ture. However, leptin treatment of WT or ob/ob mice at 30C
again did not lead to any significant increase in EE (Figures 1F,
1G, and S1C), while the effects on food intake were maintained
(Figure 1H). Thus, our results demonstrate the absence of an
acute thermogenic effect of leptin.ors
Figure 2. Leptin Affects the Defended Tb at Subthermoneutral Temperatures
(A–H) Male WT (body weight = 27.4 ± 0.5 g) and ob/ob (body weight = 48.1 ± 1.0 g) mice were exposed to different environmental temperatures from 33C to 16C.
In (A)–(D), Scholander plots ofWTmice treatedwith saline (C) or leptin (-) and ob/obmice treatedwith saline (B) or leptin (,) are shown. The values are average
EE for the last hour at each temperature. (E–H) Tb within the same time frame. Note that the data presented in (A) and (E) and (D) and (H) are a reorganization of the
data presented in (B) and (F) and (C) and (G). Ta, ambient temperature.
(I and J) For thermal preference tests, male WT and ob/ob mice, injected with saline or leptin, were allowed to move freely in a temperature gradient tunnel during
the day, and the position of the mouse was recorded. (I) Probability distribution of WT (black) and ob/ob (white) mice for staying within pre-defined 2C regions of
the gradient. (J) Probability distribution of ob/ob mice injected with saline (white) or 5 mg/kg leptin (black) 24 hr and 2 hr before start of the experiment.
n = 5–7. Data indicate means ± SEM. *p# 0.05; significant differences between treatments calculated using Student’s t test. #p# 0.05; ##p# 0.01; significant
differences between genotypes calculated using Student’s t test.
See also Figure S2 and Movie S1.ob/ob Mice Are Not Hypometabolic
As a corollary to the tenet that leptin is thermogenic, ob/ob mice
are generally described as being hypometabolic (see Introduc-
tion). We performed modified Scholander experiments (Scho-
lander et al., 1950) to measure the temperature dependence
of the effects of leptin deficiency and leptin treatment on EE,
body temperature (Tb), and locomotor activity. No effects of ge-
notype or treatment on locomotor activity were observed (Fig-
ures S2A–S2D).
WT mice (Figure 2A, filled symbols) displayed stable EE levels
at environmental temperatures between 33C and 27C (Fig-
ure 2A). This temperature range, thus, represents the thermo-
neutral zone. At environmental temperatures below 27C, theCell REE of the WT mice increased linearly with decreasing environ-
mental temperature, representing the need to perform thermo-
genesis to compensate for the increasing heat loss (Figure 2A).
The slope of the increase in EE is a function of the insulation of
the animal, since better insulation reduces the need for heat
production (Scholander et al., 1950).
In ob/ob mice (open symbols), the thermoneutral zone was
also 27C–33C (Figure 2A). Remarkably, ob/ob mice showed
significantly higher EE thanWTmice. This finding was surprising,
as others have reported the metabolic rates of ob/ob mice to
be significantly lower than those of WT mice (Pelleymounter
et al., 1995). Indeed, this has been suggested to contribute to
their obese phenotype. However, the Pelleymounter data wereeports 14, 1621–1631, February 23, 2016 ª2016 The Authors 1623
normalized per kilogram of body weight rather than per mouse
(see Discussion). In Figures S2E and S2F, we have plotted the in-
dividual EE data versus body weight and, as recommended by
Tscho¨p et al. (2012), versus lean mass. As seen, the ob/ob
mice are clearly hypermetabolic when analyzed in this way,
demonstrating higher EE despite lower lean mass (Figure S2I).
As the slope of the increase in EE in the Scholander experi-
ments was not different between WT and ob/ob mice, a defect
in insulation was not driving increases in EE. The mice did not
show significant differences in food intake, as compared to WT
controls (Figure S2J), which is most likely a reflection of their
age; ob/ob mice show only a transient hyperphagic phase (Fig-
ure S1A) (Hanson and Morton, 1983). Thus, the explanation for
the higher EE of the ob/obmice cannot be a higher thermic effect
of food as a result of hyperphagia.
ob/ob Mice Are Not Hypothermic
It is generally assumed that leptin-deficient ob/ob mice display
hypothermia, i.e., they are unable to fully defend Tb due to the
(unsustainable) tenet that they are hypometabolic. Therefore,
we followed Tb during the Scholander experiments. At subther-
moneutral temperatures, the Tb of the WT mice (Figure 2E, filled
symbols) remained, as expected, principally stable at 35C
(Figure 2E).
At thermoneutrality (30C), the Tb of ob/ob mice was indistin-
guishable from that of WT mice (Figure 2E). At subthermoneutral
temperatures (below 27C) (Figure 2E), the ob/obmice displayed
Tbs that were lower than those ofWTmice (despite having higher
EE) (Figure 2A). Thus, they appear hypothermic, i.e., they appear
to be in a state where they can no longer produce sufficient heat
to compensate for heat loss. However, this was clearly not the
case. First, the Tbwas stable, even as the cold stress was further
increased (Figure 2E); second, the mice were able to increase
their metabolic rates further with the decreasing environmental
temperature (Figure 2A). Since Tb remained stable at subther-
moneutral temperatures, and the mice were fully able to defend
this lower Tb by increased metabolism, the ob/ob mice at sub-
thermoneutral temperatures are not hypothermic but rather ana-
pyrexic (i.e., they defend a lower Tb). Thus, leptin would appear
to have an effect on the central control of Tb.
Leptin Normalizes the Defended Tb Setting
Since ob/obmice displayed a lower Tb thanWTmice at subther-
moneutral temperatures, the effects of leptin treatment on EE
and Tb were analyzed in these mice. Leptin treatment of WT
mice did not lead to significant changes in EE (Figure 2B) but
to a slight increase in Tb at subthermoneutral temperatures
(Figure 2F). Correspondingly, during a 24-hr recording, leptin-
treated WT mice displayed a slight increase in Tb at 21C during
the light phase (Figure S1D), not paralleled by an increased EE
(Figure 1C), while at 30C, no Tb effect was observed in WT
mice during acute recording (Figure 2F) and 24-hr recording
(Figure S1G).
Leptin treatment of ob/obmice did not increase EE at any tem-
perature (Figure 2C). Despite not increasing EE, leptin treatment
of ob/obmice led to a robust elevation of Tb at all subthermoneu-
tral temperatures (Figure 2G). Indeed, leptin treatment of ob/ob
mice led to Tbs statistically indistinguishable from those of WT1624 Cell Reports 14, 1621–1631, February 23, 2016 ª2016 The Authmice (Figure 2H) but did not eliminate the difference in EE
between the WT and ob/ob mice (Figure 2D). Correspondingly,
during a 24-hr recording, the leptin-treated ob/ob mice at 21C
displayed an increased Tb both during the light phase and during
most of the dark phase (Figure S1E), again, not paralleled by an
increased EE (Figure 1D). At 30C, no effect of leptin treatment
on Tb was seen during the 24-hr recording (Figure S1H).
Leptin Counteracts the Development of Torpor
Due to the relationship between leptin and food intake, we exam-
ined whether the absence of food during the experiments would
affect EE. Even in fasted mice, there was no significant effect of
leptin on EE, neither at 30C nor at 21C, and neither in wild-type
nor in ob/ob mice (Figures S2G and S2H). The tendency to an
increase in EE in ob/ob mice at 21C probably merely represents
a counteraction of fasting-induced torpor (discussed in the
following text).
In an extension of this, we pair-fed ob/ob mice to ob/ob mice
that received leptin injections and thus reduced their food intake.
As expected, during the light phase, leptin treatment prevented
the pair-feeding-induced drop in Tb (Figures S1E, S1F, S1H,
and S1I). The effect of leptin during the dark phase was much
more pronounced. In agreement with earlier data (Himms-
Hagen, 1985; Webb et al., 1982), the pair-fed mice, in the relative
cold of 21C and in the absence of sufficient food, went into
torpor at the end of the night: the Tb dropped conspicuously
(Figure S1E). The much-lowered Tb resulted necessarily in a
diminished metabolic rate (Figure S1F). However, through its py-
rexic effect, leptin prevented the torpor; the mice defended their
Tb; and there was, accordingly, no decrease in metabolic rate.
Mice at thermoneutrality could, for obvious reasons, not display
full torpor, but the metabolic pattern was similar (Figures S1H
and S1I). Thus, leptin acted by maintaining the Tb at a euthermic
level counteracting torpor induction (Bolze et al., 2015; Do¨ring
et al., 1998; Gavrilova et al., 1999; Stehling et al., 1996).
Thermal Preference Behavior Is Not Affected by Leptin
The stable but reduced Tb in ob/ob mice at subthermoneutral
temperatures and the immediate correction of this phenotype
after leptin treatment could be explained by a shift in Tb set-
point. In that case, the ob/ob mice should also defend the lower
Tb at higher environmental temperatures. This does not seem to
be the case (Figure 2E). However, the concept of a set-point is
controversial. There may not be a central set point but, rather,
an array of effector mechanisms with different thresholds
(McAllen et al., 2010; Romanovsky, 2004), which results in
the apparent existence of a common set point. Therefore, we
examined whether other thermoregulatory effectors were also
affected by leptin. For this, we used a thermal preference test.
In this test, the mice, during daytime, are allowed to move freely
in a channel with a defined temperature gradient to choose their
preferred temperature; thus, they utilize behavioral rather than
metabolic thermoregulation (Movie S1).
The experiments revealed nomeasurable differences between
WT and ob/ob mice (Figure 2I), indicating no inherent difference
in the preferred temperature. Similarly, leptin replacement in
ob/ob mice did not alter the thermal preference behavior (Fig-
ure 2J). This lack of difference in preferred temperature betweenors
WT and ob/obmice is parallel to findings in the Scholander tests,
showing the same range of the thermoneutral zone in both
genotypes.
ob/ob Mice Do Not Have Reduced BAT Thermogenic
Capacity
Based on the tenet that ob/ob mice are hypometabolic and
hypothermic (a tenet that, according to the studies discussed
earlier, is not sustainable), a failure in the thermogenic processes
in thesemice has been suggested (see Introduction). As all adap-
tive, facultative, non-shivering thermogenesis is located to BAT
(Golozoubova et al., 2001), any failure in the capacity for non-
shivering thermogenesis must be located in BAT. Analysis of
interscapular BAT (IBAT) revealed a significantly higher tissue
weight in ob/ob mice (Figure 3A), but with a lower protein density
(Figure 3B), resulting in the total protein content of the tissue
being the same in WT and ob/ob mice (Figure 3C). Thus, the
increase in tissue weight reflects a massive accumulation of
lipids in ob/ob BAT but does not demonstrate tissue atrophy.
To analyze the ability of BAT to perform non-shivering thermo-
genesis, uncoupling protein 1 (UCP1) levels in WT and ob/ob
mice were measured. This revealed essentially equal amounts
of UCP1 per milligram of protein in the two genotypes (Figures
3D and 3F). Since the IBAT protein content and the amount of
UCP1 per milligram of protein were similar, the total UCP1 levels
in the total IBAT depot were the same in WT and ob/ob mice
(Figure 3G) (despite lower UCP1 content per milligram of tissue;
Figure 3E). This parameter, i.e., the total amount of UCP1 in the
tissue, is generally accepted to be themost relevant biochemical
parameter for non-shivering thermogenic capacity of BAT (Can-
non and Nedergaard, 2004; Virtue and Vidal-Puig, 2013). Thus,
the absence of leptin does not decrease non-shivering thermo-
genic capacity.
We also directly assessed the non-shivering thermogenic
capacity of BAT in ob/ob versusWTmice, using the sympathetic
neurotransmitter norepinephrine. These experiments revealed a
similar response to norepinephrine in WT and ob/ob mice (Fig-
ure 3H), which is, thus, in accordance with the similar levels of
total UCP1 protein (Figure 3G).
Therefore, the only difference between BAT in WT and ob/ob
mice is the large lipid accumulation in the ob/ob mice. Lipid
deposition is usually a reflection of inactive BAT, but the lack
of BAT atrophy observed in the ob/ob mice (i.e., the absence
of decreased UCP1 levels) does not support an inactive state.
Rather, it would seem that the total lipid content of the ob/ob
mice is so high that lipid is forced into all tissues—and the rate
of combustion in BAT is inadequate to counteract this.
Leptin Treatment Reduces Tail Heat Loss in ob/ob Mice
Since Tb in ob/ob mice after leptin treatment at subthermoneu-
tral temperatures was increased without EE being increased, we
speculated that a decreased heat loss could generate the
increase in Tb. The tail is a major thermoregulatory organ in
the mouse, being very important for heat dissipation (Gordon,
1990; Warner et al., 2013). Thus, changes in tail surface temper-
ature, indicating vasoconstriction or vasodilation, can be used as
a readout for changes in heat loss. Therefore, we used infrared
thermography to measure the tail temperature.Cell RLeptin treatment of WT mice did not significantly influence tail
temperature. However, in ob/ob mice, leptin treatment resulted
in a significant decrease in tail temperature (Figures 3I and 3K).
This effect was evident also when tail temperature was normal-
ized to Tb (Figure 3L). Thus, an increased tail vasoconstriction
and, thus, a decrease in heat loss contributed to or fully explained
the increase in Tb in ob/ob mice following leptin injections at
subthermoneutral environmental temperatures. Thus, a robust
increase in Tb occurred in the absence of any increased EE.
Prolonged Leptin Treatment Is Markedly Pyrexic
In the aforementioned studies, where acute effects of leptin were
followed, increased Tb was observed in ob/ob mice, but not
in WT mice, following leptin injections at subthermoneutral
temperatures. An increased Tb results in a larger difference be-
tween the environmental temperature and the Tb, thus principally
increasing themagnitude of the cold stress. To elucidatewhether
this increase in cold stress would eventually lead to a higher de-
gree of BAT recruitment, we treated ob/ob mice twice daily with
leptin for 5 days. The experiments were carried out both at
21C, where we expected to see effects on Tb, and at 30C,
where no effect was expected. As no effects of leptin on Tb
were observable inWTmice, suchmicewere not examined here.
At 21C, the saline-treated ob/obmice showed large circadian
fluctuations of Tb (Figure 4A). Leptin treatment significantly
increased Tb within the first light phase of the treatment (Fig-
ure 2; Figures 4A and 4B). During the whole treatment period,
Tbwas increased in the leptin-treated group, and the daily ampli-
tude was reduced (Figures 4A–4C). With time, both light-phase
and dark-phase Tb in the leptin-treated mice approached a
plateau-like state, with light-phase Tb being 2.5C higher and
dark-phase Tb being 1.5C higher than in the saline controls.
Despite this robust increase in Tb, leptin treatment again did
not lead to significant changes in EE (Figures 4D and 4E).
At 30C, leptin treatment did not cause any acute changes in
Tb of ob/ob mice (Figure 2; Figures 4F–4H). However, after
some days, Tb was consistently about 0.5C higher than in those
mice treated with leptin at 21C. Leptin treatment acutely (but
transiently) reduced EE (Figures 4I and 4J) and thermal conduc-
tance (Figures S4A and S4D). The decrease was not due to a
decreased thermic effect of food as a result of reduced food
intake, since food intake remained low throughout the entire
treatment period (Figure S3E).
During the chronic leptin treatment, we observed the expected
changes in body weight, body composition, food intake, and
locomotor activity (Figure S3).
Prolonged Leptin Treatment Does Not Recruit BAT in
ob/ob Mice
The prolonged leptin treatment of ob/ob mice resulted in a
decrease in IBAT tissue weight (Figure 5A). At 21C, leptin treat-
ment of ob/ob mice resulted in a massive decrease in lipid
droplet size and number in IBAT, as assessed by histological
and protein analysis (Figures 5B and S4G). At 30C, there were
minor, and less homogeneous, effects of leptin treatment on
BAT morphology. The total protein content of the IBAT was
reduced by the prolonged leptin treatment at both environmental
temperatures (Figure 5C).eports 14, 1621–1631, February 23, 2016 ª2016 The Authors 1625
Figure 3. ob/ob Mice Do Not Display Reduced BAT Thermogenic Capacity, and Leptin Treatment Reduces Tail Heat Loss in ob/ob Mice
(A–H) WT mice (black) and ob/ob mice (white) housed at 21C were analyzed. (A) Tissue weight of IBAT. (B) IBAT protein density. (C) IBAT total protein content,
calculated as (A)3 (B). (D) Quantification of UCP1 levels shown in (F); WTwas set to 1. (E) UCP1 permilligram of tissue calculated from (B) and (E);WTwas set to 1.
(F) UCP1 western blot analysis of 20 mg IBAT protein lysate samples. A pooled IBAT lysate was used routinely as standard (S) on all blots. Total protein kinase B
(Akt) was used as a loading control. (G) Total UCP1 content per IBAT depot, calculated as (C)3 (E); WT was set to 1. (H) Functional analysis of BAT thermogenic
capacity using the norepinephrine (NE)-injection test in animals anesthetized with pentobarbital. Increase over baseline after norepinephrine injection is shown in
milliliters per minute. Baseline levels were 0.68 ± 0.02 for WT and 0.76 ± 0.08 for ob/ob.
(I–L) Infrared thermography analysis. (I) Tail temperatures measured 0.5 cm from the tail base of WT and ob/ob mice treated with saline or leptin. Arrows indicate
the region of interest. (J) Rectal temperatures of WT and ob/ob mice. (K) Compilation of the results of experiments as those shown in (I). (L) The differences
between tail temperatures and rectal temperatures. In (J)–(L), red arrows indicate a significant leptin effect.
For (A)–(G): n = 5–7; for (H), n = 4–5; for (I)–(L), n = 5–7. Data indicate means ± SEM. (*)p < 0.1 **p# 0.01, significant differences between treatments calculated
using Student’s t test. #p# 0.05; ##p# 0.01; ###p# 0.001, significant differences between genotypes calculated using Student’s t test.
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Figure 4. Prolonged Leptin Treatment Is Markedly Pyrexic
Male ob/ob mice were exposed to 21C or 30C in the indirect calorimetry system and treated twice daily with saline or 2.5 mg/kg leptin for 5 days, starting after
24 hr of acclimation to the calorimetry chambers. Tbs (A–C, F–H) and EE (D, E, I, and J) were followed. Data indicate means ± SEM; n = 5. *p# 0.05; **p# 0.01;
***p# 0.001, significant differences between treatments calculated using Student’s t test.
See also Figures S3 and S4.The prolonged leptin treatment at 21C significantly induced
UCP1 levels per milligram of protein (Figures 5D and 5F). How-
ever, since the total protein content of the IBAT was significantly
reduced (Figure 5C), there was no significant difference between
saline- and leptin-treated animals in total UCP1 per IBAT depot
(Figure 5G). Also at 30C, UCP1 levels remained unchanged (Fig-
ures 5E and 5G).
Thus, the biochemical data imply an absence of BAT
recruitment due to prolonged leptin treatment. To investigate
whether this was reflected physiologically, we performed
norepinephrine-injection experiments in the chronically lep-
tin-treated mice. Leptin treatment did not influence the
magnitude of the norepinephrine-induced oxygen consump-
tion, neither at 21C nor at 30C (Figures 5H and 5I).
These results are, thus, in agreement with the observed
absence of any increase in total BAT UCP1 content
(Figure 5G).Cell RDISCUSSION
In the present study, we found that leptin-deficient ob/ob mice
are neither hypometabolic nor hypothermic. Analysis of BAT
recruitment and thermogenic capacity revealed no defect in
ob/ob mice. Leptin administration to WT and ob/ob mice did
not lead to a thermogenic response; leptin treatment of ob/ob
mice resulted in a defended increase in Tb that was probably
mediated by reduced heat loss through tail vasoconstriction.
Thus, leptin is not thermogenic but is pyrexic.
Leptin-Deficient Mice Are Not Hypo- but Rather
Hypermetabolic
That ob/ob mice should be hypometabolic, and that this phe-
nomenon—in addition to their hyperphagia—causes their obese
phenotype, hasmainly been based on the report that ob/obmice
display lower EEwhen this is normalized by bodyweight and thateports 14, 1621–1631, February 23, 2016 ª2016 The Authors 1627
Figure 5. Prolonged Leptin Treatment Does Not Recruit BAT in ob/ob Mice
(A–I) BAT thermogenic capacity of the mice examined in Figure 4 was analyzed as described in Figure 3. UCP1 content (A–G) as well as norepinephrine (NE)
response (H and I) were measured. (H and I) Baseline at 21C: saline, 0.74 ± 0.09; leptin, 0.56 ± 0.03. Baseline at 30C: saline, 0.52 ± 0.02; leptin, 0.56 ± 0.1.
n = 4–5. Data indicate means ± SEM. (*) p < 0.1 *p# 0.05; **p# 0.01; ***p# 0.001, significant differences between treatments calculated using Student’s t test.
See also Figure S4.leptin treatment increases EE when it is expressed in this way
(Pelleymounter et al., 1995). Accordingly, even the data pre-
sented here would indicate hypometabolism in ob/ob mice
when expressed in this way (9.8 ± 0.8 mW/g body weight in
ob/ob versus 14.4 ± 0.7 mW/g in WT), as well as an effect of pro-
longed leptin treatment (from 12.1 ± 0.3 to 16.2 ± 0.4 mW/g body
weight). However, as pointed out earlier and as previously
emphasized (Butler and Kozak, 2010; Cannon and Nedergaard,
2011; Himms-Hagen, 1997; Nedergaard and Cannon, 2014;
Tscho¨p et al., 2012), this way of normalizing the data will lead
to erroneous conclusions, since it does not distinguish between
metabolically active tissue and metabolically inert lipids, which
account for the increased body weight seen in ob/ob mice
(Figure S2I).
In contrast to the generally accepted concept of hypometab-
olism, our data indicate that ob/ob mice are actually hypermeta-
bolic (see also Kaiyala et al., 2015). The hypermetabolism is not
a reflection of the energetic costs of increased food intake, as
the mice were not hyperphagic, nor could a larger lean mass
account for the hypermetabolism of ob/ob mice, since the lean
mass of ob/ob mice was not larger (Figure S2I). It may be spec-
ulated that the increased metabolism in ob/ob mice is a reflec-
tion of the extra EE needed simply to carry the increased fat1628 Cell Reports 14, 1621–1631, February 23, 2016 ª2016 The Authmass. However, we (Figure S2K) and others (Abreu-Vieira
et al., 2015; Bray and York, 1979; Pelleymounter et al., 1995;
Porter et al., 2013) found reduced locomotor activity in obese
mice. Thus, it seems likely that the mice compensate for the
increased cost of movement by reducing their activity. The hy-
permetabolism has also been interpreted to be a reflection of
reduced insulation (Kaiyala et al., 2015). However, our data on
tail heat loss (Figure 3), as well as the Scholander experiments
(Figure 2A), do not provide any support for this hypothesis. The
hypermetabolism is, therefore, not understood. The develop-
ment of obesity in ob/ob mice is likely due to hyperphagia at a
young age (Figure S1A) rather than to decreased thermogenesis.
Leptin-Deficient Mice Are Anapyrexic but Not
Hypothermic
The reduced Tb of ob/ob mice at subthermoneutral tempera-
tures has been interpreted as hypothermia (Bray and York,
1979; Kaiyala et al., 2015; Pelleymounter et al., 1995), which is
defined as an inability to defend the Tb in the cold. However,
we and others (Trayhurn and James, 1978) have found the Tb
of ob/ob mice to be substantially lower than that of WT mice,
but stable at subthermoneutral temperatures; particularly, we
observed that the Tb did not decrease further when the degreeors
of cold stress was further increased (Figure 2A). This state may,
therefore, be defined as being an anapyrexic state, which means
that the ob/ob mice defend a Tb that is lower than the defended
Tb of WT mice. However, thermal preference tests, which we
(Figure 2) and others (Carlisle and Dubuc, 1984) performed to
analyze behavioral thermogenesis, revealed similar temperature
preference inWT and ob/obmice. This indicates that ob/obmice
have changed thresholds of certain thermoregulatory effectors
(see diagram in Figure S5). While the mice defend a lower Tb
at subthermoneutral temperatures, when given the opportunity,
they will behaviorally raise their Tb to WT levels.
BAT Is Not Atrophied in Leptin-Deficient Mice
The apparent hypothermia and hypometabolism of the ob/ob
mice have been interpreted as being a reflection of reduced
BAT non-shivering thermogenic capacity (see Introduction). In
the present study, we found no evidence for reduced BAT ther-
mogenic capacity. Although the tissue was filled with lipid, total
UCP1 levels and norepinephrine responses were similar in WT
and ob/obmice (Figure 3) (Wilson et al., 1984). Therefore, despite
massive lipid accumulation, the adrenergic responsiveness
(Gong et al., 1997; Ricquier et al., 1986) and the recruitment state
of BAT in ob/ob mice were not different from those in WT mice,
nor were UCP1 mRNA levels diminished (Gong et al., 1997;
Harris et al., 1998; Jacobsson et al., 1985; Ricquier et al.,
1986). Furthermore, since the ob/ob mice are neither hypometa-
bolic nor hypothermic, there is no a priori reason to expect an
atrophied state of BAT, and the increased lipid accumulation is
an effect of an overall high lipid load rather than of an inability
of BAT to combust the lipid.
Leptin Is Not Thermogenic but Is Pyrexic
We and others observed no thermogenic response to leptin in
either WT or in ob/ob mice (Do¨ring et al., 1998; Ho¨gberg et al.,
2006; Mistry et al., 1997; Rafael and Herling, 2000; Ukropec
et al., 2006), at least within the accuracy of the methods used.
While thermogenic effects of drugs can be masked by changes
in thermoregulatory thermogenesis when administered at sub-
thermoneutral temperatures, we were also unable to detect
effects at thermoneutrality. We also found no effect in young,
hyperphagic ob/ob mice (Figure S1). Norepinephrine turnover
in BAT of ob/ob mice is not significantly lower than that of WT
mice at thermoneutrality or in moderate cold (Zaror-Behrens
and Himms-Hagen, 1983). Nonetheless, some studies reported
increasedBAT norepinephrine turnover in ob/obmice due to lep-
tin treatment (Collins et al., 1996) or increased BAT sympathetic
nerve activity in rats (Morrison, 2004).Wedetected neither a ther-
mogenic responsenor an inductionofUCP1expression following
acute or prolonged leptin treatment. There are reports, based on
the results of pair-feeding experiments, that the presence of
UCP1 augments the weight-diminishing effect of leptin on fat
depots (body weight is not affected) (Commins et al., 2001; Oka-
matsu-Ogura et al., 2007). However, the extent of the repression
of food intake during leptin treatment is also decreased in the
absence of UCP1 (Commins et al., 2001; Okamatsu-Ogura
et al., 2007, 2011). This confounds the analysis of such studies.
Although we did not observe any thermogenic effect of leptin
treatment, we observed a robust increase in Tb of ob/ob miceCell Rfollowing leptin treatment (Figures 2, 4, and S1). An increase in
Tb of ob/ob mice has been reported for mice at room tempera-
ture (Pelleymounter et al., 1995; Singh et al., 2009; Ukropec
et al., 2006), but, following prolonged leptin treatment, we also
observed an increase in Tb at thermoneutrality (Figures 4G and
4H). Tb in WT mice also tended to be increased following leptin
treatment (Figures 2 and S1). This is principally in agreement with
experiments showing increased Tb in rats (De Fanti et al., 2002;
Luheshi et al., 1999) or mice (Dodd et al., 2014) after leptin treat-
ment. In the ob/ob mice, this pyrexic effect of leptin is most likely
mediated by the ability to markedly decrease tail heat loss (Fig-
ure 3). Since leptin, applied in situ, has been reported to have the
opposite action, i.e., a vasodilatory action, on the endothelium
(Gu and Xu, 2013), the vasoconstrictory action that we observed
is presumably mediated by leptin acting centrally on the sympa-
thetic nervous system (Gu and Xu, 2013).
The way leptin alters the threshold temperature for thermoreg-
ulatory thermogenesis is not currently known. Leptin receptors
are found in the preoptic chiasma anterior hypothalamus area
(POAH) in the brain (Zhang et al., 2011), an area that is central
for body temperature control. However, there is currently no
detailed knowledge about how the thresholds for effectors of
body temperature regulation are regulated, but the mechanism
of leptin interactionwith these processes is a challenging innova-
tive area for understanding the function and significance of leptin.
Conclusions
For more than three decades, ob/ob mice have generally been
considered to be hypometabolic and hypothermic and to have
defective BAT. Subsequently, soon after its identification in
1994, leptin has been considered to be thermogenic and acting
partly through BAT (re)activation. The data presented here seri-
ously challenge these concepts. Whereas it is likely that, in a
certain strain of mice—the Aston strain—the ob/ob genotype is
associated with BAT atrophy (Ashwell et al., 1985; Thurlby and
Trayhurn, 1980; Trayhurn and James, 1978; Wilson et al.,
1984), this is clearly not a general effect of this genotype, and
obesity can clearly develop in the ob/ob mice without the addi-
tion of the effect of an increased metabolic efficiency caused
by the absence of UCP1 activity. Similarly, leptin can, at least
in mice, clearly decrease obesity without the contribution of ex-
tra thermogenesis from BAT. Metabolically, the present studies
should, therefore, help in directing further efforts concerning lep-
tin action into its effects on themechanisms of body temperature
control.
EXPERIMENTAL PROCEDURES
Please see the Supplemental Experimental Procedures for additional details.
All experiments were approved by the Animal Ethics Committee of the North
Stockholm Region.
Animals
Routinely, male 12- to 24-week-old C57BL/6 Lepob/JRj mice and lean litter-
mates (Janvier Labs) were used in this study. As thesemice result from hetero-
zygote crossings, the lean controls used in this study were either +/+ or +/ob;
both these genotypes are referred to as WT. The mice were housed in single
cages at 21C, with free access to water and the chow diet R70 (Lactamin)
on a 12-hr/12-hr light/dark cycle. In the injection experiments, the mice wereeports 14, 1621–1631, February 23, 2016 ª2016 The Authors 1629
routinely either injected with sterile saline or 5mg/kg body weight recombinant
murine leptin (PeproTech). Indirect calorimetry measurements of non-anes-
thetized mice were either performed at 21C or 30C on a 12-hr/12-hr light/
dark cycle. For measurement of Tb and locomotor activity in three dimensions,
the animals were implanted intraperitoneally with telemetric transponders. Tail
temperatures were measured at room temperature, using a FLIR T335 infrared
camera as described by Hoefig et al. (2015).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.01.041.
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